glp 1 agonist lilly Diabetes Patients Also Struggle to Access GLP-1 Agonists Eli Lilly to seek approval
Description
2A, bottom
Mol Cell Endocrinol 2009
K.WillerC
In June, Canadian health officials approved a generic version of Novo Nordisks Wegovy medication to be used as a treatment for weight loss
The outcomes assessed included glycemic control, weight management, lipid profiles, and the incidence of adverse events
